By
Drug Target Review2025-06-17T08:30:19
Researchers at the University of Alabama have identified reelin, a glycoprotein known for its role in brain development, as a key regulator of neurons in the brain's reward centre, potentially making way for targeted therapies against cocaine use.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, By Drug Target Review
2026-09-03T07:00:00
Contributor Marty Parrish and Steve Hoffmann, By Drug Target Review
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2026-10-26T06:23:00
Author Amine Bouchareb
2024-01-09T09:30:19
Sponsored by Sartorius
2024-02-06T08:57:06
Sponsored by bit.bio
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud